LabConnect

Founded in 2002, LabConnect provides global central laboratory services including routine and esoteric laboratory testing, kit building, sample management and tracking, biostorage and scientific support services for biopharmaceutical and CRO clients. LabConnect currently has locations worldwide and central laboratory capabilities on six continents. LabConnect’s service suite includes: Specialized Testing. With more than 4,000 validated tests across our network, LabConnect can handle everything from general safety testing to the most complex molecular diagnostics and biomarker analyses. Specimen Tracking. LabConnect’s real-time specimen tracking service, SampleGISTICS™, follows the clients’ specimen samples from collection through logistics to receipt at any lab or storage location in the world.a

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMA TECH

PFIZER, BIONTECH COVID-19 VACCINE WORKS IN MORE CONTAGIOUS CORONAVIRUS VARIANTS

Pfizer | January 11, 2021

news image

Newly emerged variants of the novel coronavirus have sparked a key question: Will existing COVID-19 vaccines be less effective against them? But scientists have preliminary data showing that may not be the case, at least for Pfizer and BioNTech’s shot. Researchers from the University of Texas and Pfizer found that, in lab dishes, the vaccine was able to neutralize an engineered version of a variant, which bears an N501Y mutation in its spike protein. The finding was publishe...

Read More

RESEARCH

RHYTHM PHARMACEUTICALS RECEIVES FDA APPROVAL FOR OBESITY MED TARGETING GENETIC DEFECTS

Rhythm | December 01, 2020

news image

Stoutness is a significant issue around the world, in any case, for a small amount of patients, hereditary changes instead of propensities are driving the sickness. With its new FDA endorsement for Imcivree, Rhythm Pharmaceuticals is venturing out treating those cases. For a subset of heftiness patients, hereditary transformations leave them with an "voracious appetite," Rhythm CEO David Meeker, M.D., said in a meeting. Beginning stage hereditary illnesses can leave pati...

Read More

ZEALAND PHARMA STRENGTHENS EXECUTIVE TEAM WITH NEW U.S. LEADERSHIP

Globe newswire | June 15, 2020

news image

Zealand Pharma, a biotechnology company changing lives with innovative peptide-based medicines, today announced the appointment of Frank Sanders as President of Zealand Pharma U.S. Frank will join Zealand on July 6, 2020. “I am pleased to welcome Frank Sanders to Zealand Pharma, and am confident that he will provide strong and experienced leadership for our U.S. organization,” said Emmanuel Dulac, President and Chief Executive Officer at Zealand Pharma. “Frank has more than 25 ...

Read More

PHARMACY MARKET

ULTIVUE ANNOUNCES CO-MARKETING AGREEMENT WITH AIGNOSTICS FOR UNIQUE SPATIAL AI-POWERED IMAGING SOLUTIONS FOR TRANSLATIONAL MEDICINE

Ultivue, Inc., | March 10, 2022

news image

Ultivue, Inc., an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, and Aignostics GmbH, a global leader in Artificial Intelligence (AI) powered precision diagnostics focused on pathology to assist with research, clinical trials and CDx development, announced a partnership to collaborate on the co-development of AI-powered spatial multiplexed immunophenotype solutions for translational research groups and Biopharma. The companie...

Read More
news image

PHARMA TECH

PFIZER, BIONTECH COVID-19 VACCINE WORKS IN MORE CONTAGIOUS CORONAVIRUS VARIANTS

Pfizer | January 11, 2021

Newly emerged variants of the novel coronavirus have sparked a key question: Will existing COVID-19 vaccines be less effective against them? But scientists have preliminary data showing that may not be the case, at least for Pfizer and BioNTech’s shot. Researchers from the University of Texas and Pfizer found that, in lab dishes, the vaccine was able to neutralize an engineered version of a variant, which bears an N501Y mutation in its spike protein. The finding was publishe...

Read More
news image

RESEARCH

RHYTHM PHARMACEUTICALS RECEIVES FDA APPROVAL FOR OBESITY MED TARGETING GENETIC DEFECTS

Rhythm | December 01, 2020

Stoutness is a significant issue around the world, in any case, for a small amount of patients, hereditary changes instead of propensities are driving the sickness. With its new FDA endorsement for Imcivree, Rhythm Pharmaceuticals is venturing out treating those cases. For a subset of heftiness patients, hereditary transformations leave them with an "voracious appetite," Rhythm CEO David Meeker, M.D., said in a meeting. Beginning stage hereditary illnesses can leave pati...

Read More
news image

ZEALAND PHARMA STRENGTHENS EXECUTIVE TEAM WITH NEW U.S. LEADERSHIP

Globe newswire | June 15, 2020

Zealand Pharma, a biotechnology company changing lives with innovative peptide-based medicines, today announced the appointment of Frank Sanders as President of Zealand Pharma U.S. Frank will join Zealand on July 6, 2020. “I am pleased to welcome Frank Sanders to Zealand Pharma, and am confident that he will provide strong and experienced leadership for our U.S. organization,” said Emmanuel Dulac, President and Chief Executive Officer at Zealand Pharma. “Frank has more than 25 ...

Read More
news image

PHARMACY MARKET

ULTIVUE ANNOUNCES CO-MARKETING AGREEMENT WITH AIGNOSTICS FOR UNIQUE SPATIAL AI-POWERED IMAGING SOLUTIONS FOR TRANSLATIONAL MEDICINE

Ultivue, Inc., | March 10, 2022

Ultivue, Inc., an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, and Aignostics GmbH, a global leader in Artificial Intelligence (AI) powered precision diagnostics focused on pathology to assist with research, clinical trials and CDx development, announced a partnership to collaborate on the co-development of AI-powered spatial multiplexed immunophenotype solutions for translational research groups and Biopharma. The companie...

Read More